Medicine & Health

Researchers at the School of Medicine have identified ingredients for snack food prototypes that have been formulated to deliberately change the gut microbiome in ways that can be linked to health.

Catherine Lang, professor of physical therapy at the School of Medicine, has been appointed to serve on a national child health council for the Eunice Kennedy Schriver National Institute of Child Health and Human Development of the National Institutes of Health (NIH).

Lora Iannotti, associate professor at the Brown School and an expert on maternal and child nutrition, spoke during a panel discussion in June about the launch of the UN Nutrition discussion paper on livestock-derived foods and sustainable healthy diets.

A study led by researchers at Washington University School of Medicine has identified a protein in the immune system that may protect babies from necrotizing enterocolitis, a leading cause of death among premature infants.

Researchers at Washington University School of Medicine and Cornell University have implanted insulin-secreting cells into diabetic mice to normalize their blood sugar.

Eating a Western diet impairs the gut’s immune system in ways that could increase risk of infection and inflammatory bowel disease, according to a study from the Washington University School of Medicine and Cleveland Clinic.

The Clinical Research Forum, a nonprofit association of top clinical research experts from the nation’s leading academic health centers, has awarded an international interdisciplinary team led by Jeffrey I. Gordon, MD, a Distinguished Clinical Research Achievement Award for his study “Integrating Global Health with the Microbiome.”

School of Medicine researchers have found that although the vast majority of people with alcohol use disorder see their doctors regularly, fewer than one in 10 ever get treatment to help curb their drinking.

A new study led by the School of Medicine has found a link between consuming sugary drinks and an increased risk of colorectal cancer among women under 50. The findings could help explain the rising rates of colorectal cancer among younger adults.

In the first clinical trial of nicotinamide mononucleotide (NMN), School of Medicine researchers have found that the compound previously demonstrated to counteract aspects of aging and improve metabolic health in mice also has clinically relevant effects in people.